Results 41 to 50 of about 147 (74)

Casein Kinase 1δ Stabilizes Mature Axons by Inhibiting Transcription Termination of Ankyrin. [PDF]

Dev Cell, 2020
LaBella ML, Hujber EJ, Moore KA, Rawson RL, Merrill SA, Allaire PD, Ailion M, Hollien J, Bastiani MJ, Jorgensen EM.   +9 more
europepmc   +1 more source

β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.

Oncogene, 2021
Lu Y, Li X, Liu H, Xue J, Zeng Z, Dong X, Zhang T, Wu G, Yang K, Xu S.   +9 more
europepmc   +1 more source

CK1δ as a potential therapeutic target to treat bladder cancer. [PDF]

Aging (Albany NY), 2020
Lin YC, Chen MC, Hsieh TH, Liou JP, Chen CH.   +4 more
europepmc   +1 more source

The APC/C and CK1 in the developing brain. [PDF]

Oncotarget, 2015
Penas C, Hatten ME, Ayad NG.
europepmc   +1 more source

CK1δ/ε protein kinase primes the PER2 circadian phosphoswitch. [PDF]

Proc Natl Acad Sci U S A, 2018
Narasimamurthy R, Hunt SR, Lu Y, Fustin JM, Okamura H, Partch CL, Forger DB, Kim JK, Virshup DM.   +8 more
europepmc   +1 more source

Site-specific phosphorylation of casein kinase 1 δ (CK1δ) regulates its activity towards the circadian regulator PER2. [PDF]

PLoS One, 2017
Eng GWL, Edison, Virshup DM.
europepmc   +1 more source

Two Ck1δ transcripts regulated by m6A methylation code for two antagonistic kinases in the control of the circadian clock. [PDF]

Proc Natl Acad Sci U S A, 2018
Fustin JM, Kojima R, Itoh K, Chang HY, Ye S, Zhuang B, Oji A, Gibo S, Narasimamurthy R, Virshup D, Kurosawa G, Doi M, Manabe I, Ishihama Y, Ikawa M, Okamura H.   +15 more
europepmc   +1 more source

Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer. [PDF]

Bioorg Med Chem, 2018
Monastyrskyi A, Nilchan N, Quereda V, Noguchi Y, Ruiz C, Grant W, Cameron M, Duckett D, Roush W.   +8 more
europepmc   +1 more source

Tumor promoter TPA activates Wnt/β-catenin signaling in a casein kinase 1-dependent manner. [PDF]

Proc Natl Acad Sci U S A, 2018
Su Z, Song J, Wang Z, Zhou L, Xia Y, Yu S, Sun Q, Liu SS, Zhao L, Li S, Wei L, Carson DA, Lu D.   +12 more
europepmc   +1 more source

Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines. [PDF]

Int J Mol Sci, 2019
Liu C, Witt L, Ianes C, Bischof J, Bammert MT, Baier J, Kirschner S, Henne-Bruns D, Xu P, Kornmann M, Peifer C, Knippschild U.   +11 more
europepmc   +1 more source